Literature DB >> 20470804

Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.

Michele Hummel1, Terri Cummons, Peimin Lu, Lilly Mark, James E Harrison, Jeffrey D Kennedy, Garth T Whiteside.   

Abstract

Corticotropin-releasing factor (CRF) plays a major role in controlling the body's response to stress. Because painful conditions are inherently stressful, we hypothesize that CRF may act via CRF-1 receptors to contribute to the pain experience. Studies were designed to investigate whether blocking CRF-1 receptors with selective antagonists or reducing their expression with CRF-Saporin, would attenuate ulcer, inflammatory- and neuropathic-like pain. Five experimental designs were undertaken. In experiment 1, ulcer pain was induced in mice following oral administration of indomethacin, while in experiments 2 and 3, inflammatory pain was induced in rats with either carrageenan or FCA, respectively. For these studies, animals were dosed with CP-154,526 (3, 10, 30 mg/kg) and NBI 27914 (1-30 mg/kg) 1 h prior to the assessment of tactile, thermal or mechanical hypersensitivity, respectively. In experiment 4, neuropathic pain was induced. Twenty-one days following spinal nerve ligation (SNL), animals received CRF-Saporin or control. Three weeks later tactile allodynia was assessed. Similarly, in experiment 5, a separate set of rats received CRF-Saporin or control. Twenty-one days later, mechanical hyperalgesia was assessed following intraplantar carrageenan. Results from the antagonist studies showed that CP-154,526 and NBI 27914 either fully or partially reversed the referred ulcer pain with minimal effective doses (MED) equal to 3 and 10 mg/kg, respectively. Similarly, both NBI 27914 and CP-154,526 reversed the thermal and mechanical hypersensitivity elicited by carrageenan and FCA with MEDs </= 5 and 10 mg/kg, respectively. Findings from the two CRF-Saporin studies determined that pre-treatment with this toxin significantly attenuated SNL- and carrageenan-induced tactile hypersensitivity. Together, these findings suggest that CRF-1 receptors mediate pain and implicate CRF in this regard. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470804     DOI: 10.1016/j.neuropharm.2010.05.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

Review 1.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 2.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

Review 3.  The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.

Authors:  Natalia I Yarushkina; Ludmila P Filaretova
Journal:  Inflammopharmacology       Date:  2018-02-05       Impact factor: 4.473

4.  Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking.

Authors:  Anna Molander; Valentina Vengeliene; Markus Heilig; Wolfgang Wurst; Jan M Deussing; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2011-11-23       Impact factor: 7.853

Review 5.  Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.

Authors:  Y Taché
Journal:  Neurogastroenterol Motil       Date:  2015-01       Impact factor: 3.598

6.  Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.

Authors:  Ami Cohen; Jennifer Treweek; Scott Edwards; Rodrigo Molini Leão; Gery Schulteis; George F Koob; Olivier George
Journal:  Addict Biol       Date:  2013-07-22       Impact factor: 4.280

7.  Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA).

Authors:  Brandon A Baiamonte; Marta Valenza; Emily A Roltsch; Annie M Whitaker; Brittni B Baynes; Valentina Sabino; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2013-10-06       Impact factor: 5.250

8.  Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats.

Authors:  Emily A Roltsch; Brittni B Baynes; Jacques P Mayeux; Annie M Whitaker; Brandon A Baiamonte; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2013-11-20       Impact factor: 5.250

9.  Neurobiological aspects of pain in the context of alcohol use disorder.

Authors:  Jessica A Cucinello-Ragland; Scott Edwards
Journal:  Int Rev Neurobiol       Date:  2020-10-06       Impact factor: 3.230

10.  A mechanism-based approach to prevention of and therapy for fibromyalgia.

Authors:  Charles J Vierck
Journal:  Pain Res Treat       Date:  2011-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.